Gene Logic Laboratories Inc.
- UEI
- YGT2JDY1KQ53
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Entity structure
- Other
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Dengue virus vaccine study for casu/nmrc | ACC Aberdeen Proving Ground | $650,509 | |
| 0 analyze mouse blood samp LES, quantitate MPA and MP a-glucuronide in 20 plasma (serum) samp LES (no discount per… | National Institute of Child Health and Human Development | $2,800 | |
| Toxicological evaluations of potential medications to treat drug addiction | National Institute on Drug Abuse | $5,245,282 | |
| Preclinical toxicology and pharmacology of drugs | National Cancer Institute | $2,761,406 | |
| Delivery Order 266015425-00266200309C0003266015425 | NIAID DEA OA Acquisitions | $3,775,436 |
Quick answers
What is Gene Logic Laboratories Inc.'s UEI?
Gene Logic Laboratories Inc.'s Unique Entity ID (UEI) in SAM.gov is YGT2JDY1KQ53.
Is Gene Logic Laboratories Inc. registered in SAM.gov?
Gene Logic Laboratories Inc.'s SAM.gov registration expired on September 27, 2005.
What is Gene Logic Laboratories Inc.'s most recent federal award?
Gene Logic Laboratories Inc.'s most recent federal contract award is Dengue virus vaccine study for casu/nmrc (W91CRB05P0213), from ACC Aberdeen Proving Ground, on September 27, 2005.
On GovTribe
See Gene Logic Laboratories Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors